Claim: The 'dose escalation trap' refers to the practice of increasing Tirzepatide doses based on trial schedules rather than individual patient responses.
Verdict: Correct (95% confidence)
Explanation: According to the New England Journal of Medicine, tirzepatide doses are increased based on a structured schedule, with increments every four weeks during trials (nejm.org). The Cardiology Advisor notes that real-world dose escalation is slower than in trials, indicating that trial schedules are a primary driver (thecardiologyadvisor.com). Additionally, Free Medical Journals states that tirzepatide dosing is structured around gradual escalation rather than immediate high-dose treatment (freemedic...